Vivos Therapeutics plans rights offering to raise capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- S&P 500, Nasdaq eye tepid open as Middle East tensions weigh
- Fed’s Waller open to September rate hold—if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering
June 11, 2026 8:30 AM EDTLITTLETON, Colo., June 11, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (Vivos or the Company) (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment of breathing-related sleep disorders and associated chronic health conditions, including mild-to-severe obstructive sleep apnea (OSA), today announced that it intends to file a registration statement with the U.S. Securities and Exchange Commission (the SEC) for a proposed rights offering pursuant to which the Company would distribute, as a dividend, transferable subscription... More
